Name: | Description: | Size: | Format: | |
---|---|---|---|---|
96.63 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Stage III NSCLC is a heterogeneous and complex setting that requires
multimodal management. Recent advances in modern medicine led to the implementation of immuno-oncology (IO) into clinical practice. PICTuRE aims to assess the
clinical management and the IO impact on clinical outcomes in stage III NSCLC patients (pts).
Description
Keywords
Citation
Publisher
Elsevier